Sorafenib/MEK inhibitor combination inhibits tumor growth and the Wnt/β‑catenin pathway in xenograft models of hepatocellular carcinoma
Hung Huynh(Singapore General Hospital), Karl Ziegelbauer(Bayer (Germany))
Cited by 22
Related Papers
Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosis
|BMC Gastroenterology|2003|286
Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma
|International Journal of Molecular Sciences|2023|8
Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach
|International Journal of Molecular Sciences|2024|7